Search results
Results From The WOW.Com Content Network
Eurofarma is a multinational company with 100% Brazilian capital. Eurofarma Group operates in the healthcare sector, producing and marketing products and services.With a diversified presence, it operates in all the main segments, such as Medical Prescription, Over-the-Counter, Generic, Hospital and Oncology, in addition to the export and outsourcing of medicines.
EMS is the biggest domestic pharmaceutical company in Brazil. [1] Founded in the mid-1950s, the company has six industrial plants based in São Bernardo do Campo, Hortolândia and Jaguariúna, in the state of São Paulo, Manaus, Brasília and Belgrade in Serbia.
Losartan is excreted in the urine, and in the feces via bile, as unchanged drug and metabolites. [44] About 4% of an oral dose is excreted unchanged in urine, and about 6% is excreted in urine as the active metabolite. [44] The terminal elimination half-lives of losartan and EXP3174 are about 1.5 to 2.5 hours and 3 to 9 hours, respectively. [44]
Losartan, the first ARB. Angiotensin II receptor blockers (ARBs), formally angiotensin II receptor type 1 (AT 1) antagonists, [1] also known as angiotensin receptor blockers, [2] [3] angiotensin II receptor antagonists, or AT 1 receptor antagonists, are a group of pharmaceuticals that bind to and inhibit the angiotensin II receptor type 1 (AT 1) and thereby block the arteriolar contraction and ...
The Brazilian Controlled Drugs and Substances Act (Portuguese: Regulamento Técnico sobre substâncias e medicamentos sujeitos a controle especial), officially Portaria nº 344/1998, [1] is Brazil's federal drug control statute, issued by the Ministry of Health through its National Health Surveillance Agency (Anvisa).
Losartan/hydrochlorothiazide, sold under the brand name Hyzaar among others, is a fixed-dose combination medication used to treat high blood pressure when losartan is not sufficient. [1] [2] It consists of losartan, an angiotensin II receptor blocker; and hydrochlorothiazide, a thiazide diuretic. [1] [2] It is taken by mouth. [1] [2]
It delighted passersby; while Indigenous dolls can be found elsewhere in Latin America, they remain mostly absent in Brazil, home to nearly 900,000 people identifying as Indigenous in the last census.
The Brazilian Health Regulatory Agency (Portuguese: Agência Nacional de Vigilância Sanitária, Anvisa, literally National Health Surveillance Agency) is a regulatory body of the Brazilian government, created in 1999 during President Fernando Henrique Cardoso's term of office.